Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis
Key facts
- Where
- Guangzhou, ChinaSee the site
Where in China
- Zhujiang Hospital, Southern Medical UniversityGuangzhou, ChinaContact: Xin Feng, MDNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Duan Chuanzhi
- Trial code
- NCT07353736
- Record updated
- 20 January 2026
- Original description
The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and intracranial aneurysms.Read full original descriptionShow less
Hemodynamic Mechanisms, Clinical Profiles, and Prognostic Factors in Patients With Cerebral Arteriovenous Malformations and Intracranial Aneurysms: An Observational Cohort Study
The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and intracranial aneurysms.
Inclusion: Patients diagnosed with cerebral arteriovenous malformation and intracranial aneurysm confirmed by CTA, MRA, and/or DSA; Availability of complete clinical and imaging data; Provision of written informed consent by the patient or their legally authorized representative to participate in the study and undergo follow-up; Not concurrently participating in any other clinical trials that may interfere with the outcomes of this study.
Exclusion: Previous complete occlusion of the aneurysm and/or arteriovenous malformation prior to enrollment; Coexistence of other cerebrovascular diseases such as moyamoya disease, cerebral cavernous malformation, cerebral venous sinus thrombosis, etc; Absence of DSA imaging data or poor image quality that precludes accurate evaluation of key anatomical and hemodynamic parameters of the AVM and intracranial aneurysm.